loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 210192 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    ViiV Healthcare

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE (1)

    filter

    01 VIIV HLTHCARE (1)

    filter

    01 TABLET;ORAL (1)

    filter

    01 EQ 50MG BASE;EQ 25MG BASE (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag United Kingdom
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Dolutegravir Sodium; Rilpivirine Hydrochloride

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET;ORAL
      EQ 50MG BASE;EQ 25MG B...
      JULUCA
      USA
      210192
      2017-11-21
      RX
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for CTD TGA MCC DOSSIER APPLICATION 210192

      Looking for CTD TGA MCC DOSSIER APPLICATION 210192 1

      19

      ViiV Healthcare, based in United Kingdom, is a pharmaceutical company.

      One of their notable products is DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE, with a corresponding application number 210192 and regulatory information .

      proudly manufactured in the

      approval since 2017-11-21

      ViiV Healthcare's JULUCA TABLET;ORAL, medication with EQ 50MG BASE;EQ 25MG BASE of DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE.

      Post Enquiry
      POST ENQUIRY